CSIMarket
 
Veru Inc   (VERU)
Other Ticker:  
 

Veru Inc

Business Description


Veru Inc is a pharmaceutical company that focuses on developing and commercializing innovative therapeutics and diagnostics in various areas of medicine. The company operates in three segments: Commercial, Research & Development, and The Female Health Company.

In the commercial segment, Veru markets and sells pharmaceutical products directly to healthcare providers and wholesalers. This includes prescription medications such as Tamsulosin, a generic drug used to treat enlarged prostate symptoms, and Zuclomiphene citrate, a nonsteroidal estrogen receptor agonist used to increase sperm production in men.

The research and development segment is dedicated to discovering and developing new drug candidates. Veru*s pipeline includes treatments for prostate cancer, male infertility, premature ejaculation, and female sexual health. The company is actively engaged in clinical trials to evaluate the safety and efficacy of these potential therapies.

The Female Health Company, a wholly-owned subsidiary of Veru, is responsible for the development and marketing of FC2 Female Condoms. FC2 is a women-initiated barrier method of contraception designed to prevent unintended pregnancies and sexually transmitted infections (STIs). The product is distributed globally to numerous governmental and non-governmental organizations, as well as commercial users.

Veru Inc operates through a diverse range of business models, including partnerships, licensing agreements, contract manufacturing, and direct sales. The company collaborates with leading research institutions and organizations to advance its product pipeline.

Veru*s commitment to innovation and patient-centric healthcare is evident in its investment in research and development, as well as its efforts to improve access to essential healthcare products. The company places a strong emphasis on developing products that address unmet medical needs, particularly in the areas of urology and oncology.

Veru Inc was founded in 2010 and is headquartered in Miami, Florida. The company*s growth strategy consists of expanding its product portfolio through in-licensing, acquisitions, and partnerships, while also maximizing the commercial potential of its existing products.

Overall, Veru Inc is a dynamic and innovative pharmaceutical company that is dedicated to improving the lives of patients through the development of novel therapeutics and diagnostics. With a strong focus on research and a diverse product portfolio, the company aims to address critical medical needs and make a meaningful impact in healthcare.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com